Company intelligence / Profile preview

SOVAR

Quebec City, Quebec, Canada
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

SOVAR (Société de valorisation des applications de la recherche) was a Quebec-based technology transfer and valorization organization dedicated to commercializing research from Université Laval and its affiliated health centers. The company provided intellectual property management, seed funding, and business development expertise to transform academic discoveries into viable commercial products, particularly in the life sciences and medtech sectors. SOVAR was instrumental in launching numerous startups and licensing technologies to global pharmaceutical and medical device companies. In April 2021, SOVAR was merged with Aligo Innovation and Univalor to form Axelys, a centralized provincial agency for research commercialization in Quebec. During its operation, it managed a diverse portfolio of innovations ranging from novel therapeutics to advanced diagnostic tools.

Therapeutic areas
CardiovascularNeurologyInfectious DiseasesPulmonologyOncology
Modalities
Small moleculeMedical DeviceDiagnosticsBiologicDigital Health
Industry
Investors
02

Partnerships

Université LavalCHU de Québec-Université LavalInstitut universitaire de cardiologie et de pneumologie de Québec (IUCPQ)

Beyond the preview

Go deeper on SOVAR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOVAR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call